-

Okta, Inc. Investor News: Robbins LLP is Investigating Okta, Inc. (OKTA) on Behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Okta, Inc. (NASDAQ: OKTA) and its officers and directors to determine if they breached their fiduciary duties and violated securities laws by failing to disclose its security breach to investors. Okta provides identity solutions for enterprises, small and medium-sized business, universities, non-profits, and government agencies in the U.S. and internationally. Following its merger with Auth0, Inc. on May 3, 2021, Okta began providing additional Auth0 products related to cybersecurity and login solutions.

If you would like more information about our investigation of Okta, Inc.'s misconduct, click here.

What is this Case About: According to the complaint against Okta, during the class period, defendants made false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, defendants failed to disclose that Okta had inadequate cybersecurity controls, and as a result, its systems were vulnerable to data breaches. Okta ultimately did experience a data breach caused by a hacking group, which potentially affected hundreds of Okta customers. Okta initially did not disclose and subsequently downplayed the severity of the data breach. When Okta revealed the occurrence of the breach, Okta's stock price fell $2.98 per share, to close at $166.43 per share on March 22, 2022. Then, Raymond James downgraded Okta from "strong buy" to "market perform," noting, among other things, that "[w]hile partners were willing to trust Okta's track record, the handling of its latest security incident adds to our mounting concerns." Following this downgrade, the Company's stock price fell $17.88 per share, or more than 10%, to close at $148.55 per share on March 23, 2022.

Next Steps: If you acquired shares of Okta, Inc. (OKTA) securities between March 5, 2021 and March 22, 2022, you have legal options. Contact Robbins LLP for more information.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Okta, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:OKTA

Release Summary
Robbins LLP is Investigating Okta, Inc.'s (OKTA) Failure to Disclose its Security Breach on Behalf of Shareholders
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Alert: Robbins LLP Informs Investors of the Corcept Therapeutics Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Corcept Therapeutics Incorporation (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025. Corcept is a pharmaceutical company focused on the development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. For more information, submi...

ARDT Class Action Reminder: Stockholders Who Lost Money Investing in Ardent Health, Inc. Should Contact Robbins LLP for Information About Recovering Their Losses

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2025 and November 12, 2025. Ardent Health and its affiliates operate acute care hospitals and other healthcare facilities. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the allegations? Robbins LLP is Investigating...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the NuScale Power Corporation Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired NuScale Power Corporation (NYSE: SMR) Class A shares between May 13, 2025 and November 6, 2025. NuScale is a nuclear technology company focused on scalable, modular reactors. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that...
Back to Newsroom